Study title:
J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA.
J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA.
Type of medicine: Centrally authorised medicines
|
Therapeutic area: Nervous System Diseases
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: ioflupane (123l) |
ATC code: V09A B 03 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|